News

Catch up on last month's top infectious disease news coverage from Contagion®.

Researchers from the Yale School of Public Health have found that the synthetic controls method developed by Google may effectively allow them to measure the impact of vaccines.

Higher rates of self-reported drug use exist among the HIV-positive population, highlighting the need for interventions in at-risk populations.

Researchers at the Weizmann Institute of Science have discovered that phages are able to communicate with each other in order to coordinate how to best approach the infection process.

University of Washington researchers have discovered that telomeres are shorter in adults who had experienced more diarrheal infections as infants.

Researchers found the experimental vaccine could potentially inhibit severe diarrhea and pseudomembranous colitis by inducing a functional antibody response that can neutralize the two main disease-causing toxins (toxin A or B) produced by C. difficile.

The new pediatric vaccine formulation for diphtheria, tetanus, pertussis, and poliomyelitis (DTaP) may solve the issue of vaccine schedule adherence.

Centers for Disease Control and Prevention officials are reporting epidemic flu levels across the United States, along with three new pediatric deaths from the virus.

The FDA has released a Consumer Update that warns individuals that improper use of nasal rinsing devices, such as neti pots, can actually increase risk of infection.

Researchers at Rockefeller University in New York have discovered that a potent monoclonal antibody known as 10-1074 is highly effective at neutralizing various HIV strains.

Since avian influenza is continuing to spread in birds across Europe, WHO calls for stronger surveillance efforts in order to better prevent potential infection in humans.

A research group from Hokkaido University in Japan found that standard treatment for those with genotype 1 HCV should likely be switched from interferon (INF)-based therapies to INF-free direct-acting antiviral (DAA) therapies.

The Los Angeles County Department of Public Health has concluded that the measles outbreak in California has been limited to those who are unvaccinated.

The rise of the mcr-1 gene highlights the hurdles against the bigger fight that is antimicrobial resistance

A visitor to Akron City Children’s Hospital neonatal intensive care unit in Akron, Ohio, may have inadvertently exposed nearly 50 people to tuberculosis (TB) during the months of November and December of 2016.

A report warns that liver failure might be associated with nine new direct-acting antivirals (DAA).

The Joint United Nations Programme on HIV/AIDS and medical technology industry partners have announced new efforts to better diagnose bacterial infections at the recent World Economic Forum Annual Meeting in Davos, Switzerland.

The ECDC has released a software toolkit that can calculate the disability-adjusted life years for a number of infectious diseases and healthcare-associated infections.

A group of researchers recently published a study in JAMA, examining conflicts of interest (COIs) among committee members who set hepatitis C (HCV) and cholesterol management guidelines. They found that there, in fact, were COIs among committee members setting HCV management guidelines.

The Texas Department of State Health Services recently reported the first laboratory-confirmed case of Zika virus in pregnant woman who did not travel outside of the state.

Cancer specialists at the UT Southwestern Medical Center are reminding women to continue going for Pap smears even if they have received the human papillomavirus (HPV) vaccine.

Researchers have developed a new trivalent vaccine that has proven to provide powerful protection against genital herpes (HSV) in preclinical trials.

Through environmental cleaning and student-oriented education, Humber College in Toronto, Canada, has managed to quell a nasty outbreak of norovirus.

The National Institute of Allergy and Infectious Diseases (NIAID) plans to fund research projects designed to discover and develop new antibiotics to treat these troublesome bacteria.

The European Medicines Agency has fully validated Gilead’s SOf/VEL/VOX regimen to treat hepatitis C (HCV).

While we look to emerging infectious disease outbreaks and the threat of biological weapons, it's easy to forget the responsibilities of our domestic research.

A new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).

In Illinois and Wisconsin, eight individuals working at rat-breeding facilities have contracted Seoul virus.